trial · primary record
Placebo
NAFLD (Nonalcoholic Fatty Liver Disease)
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2027-07-20 |
| Primary endpoint | The change in the degree of steatosis in the Ultra Sound |
| Registry ID | NCT07900100 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:19.597Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07900100
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound